Condition: Asthma · Sponsor: University of Central Florida
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
This description comes directly from the study's public registry record.
Amoy Fraser, PhD, CCRP, PMP · 4072668742 · amoy.fraser@ucf.edu
Erica Martin, B.S. · 4072668742 · erica.martin@ucf.edu
Always discuss trial participation with your own doctor first.
| University of Central Florida | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06068335